182 related articles for article (PubMed ID: 33427298)
1. IL-3 is essential for ICOS-L stabilization on mast cells, and sustains the IL-33-induced RORγt
Drube S; Müller S; Weber F; Wegner P; Böttcher-Loschinski R; Gaestel M; Hutloff A; Kamradt T; Andreas N
Immunology; 2021 May; 163(1):86-97. PubMed ID: 33427298
[TBL] [Abstract][Full Text] [Related]
2. IL-33-activated murine mast cells control the dichotomy between RORγt
Andreas N; Weber F; Meininger I; Templin N; Gaestel M; Kamradt T; Drube S
Eur J Immunol; 2019 Dec; 49(12):2159-2171. PubMed ID: 31334837
[TBL] [Abstract][Full Text] [Related]
3. Tumor-infiltrating mast cells stimulate ICOS
Lv Y; Tian W; Teng Y; Wang P; Zhao Y; Li Z; Tang S; Chen W; Xie R; Lü M; Zhuang Y
J Adv Res; 2024 Mar; 57():149-162. PubMed ID: 37086778
[TBL] [Abstract][Full Text] [Related]
4. TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases.
Drube S; Weber F; Göpfert C; Loschinski R; Rothe M; Boelke F; Diamanti MA; Löhn T; Ruth J; Schütz D; Häfner N; Greten FR; Stumm R; Hartmann K; Krämer OH; Dudeck A; Kamradt T
Oncotarget; 2015 Oct; 6(30):28833-50. PubMed ID: 26353931
[TBL] [Abstract][Full Text] [Related]
5. IL-33 regulates cytokine production and neutrophil recruitment via the p38 MAPK-activated kinases MK2/3.
McCarthy PC; Phair IR; Greger C; Pardali K; McGuire VA; Clark AR; Gaestel M; Arthur JSC
Immunol Cell Biol; 2019 Jan; 97(1):54-71. PubMed ID: 30171775
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF-β.
Ganeshan K; Bryce PJ
J Immunol; 2012 Jan; 188(2):594-603. PubMed ID: 22156492
[TBL] [Abstract][Full Text] [Related]
7. Subthreshold IKK activation modulates the effector functions of primary mast cells and allows specific targeting of transformed mast cells.
Drube S; Weber F; Loschinski R; Beyer M; Rothe M; Rabenhorst A; Göpfert C; Meininger I; Diamanti MA; Stegner D; Häfner N; Böttcher M; Reinecke K; Herdegen T; Greten FR; Nieswandt B; Hartmann K; Krämer OH; Kamradt T
Oncotarget; 2015 Mar; 6(7):5354-68. PubMed ID: 25749030
[TBL] [Abstract][Full Text] [Related]
8. Salt-inducible kinases are required for the IL-33-dependent secretion of cytokines and chemokines in mast cells.
Darling NJ; Arthur JSC; Cohen P
J Biol Chem; 2021; 296():100428. PubMed ID: 33600797
[TBL] [Abstract][Full Text] [Related]
9. Soluble transforming growth factor beta-1 enhances murine mast cell release of Interleukin 6 in IgE-independent and Interleukin 13 in IgE-dependent settings in vitro.
Lyons DO; Plewes MR; Pullen NA
PLoS One; 2018; 13(11):e0207704. PubMed ID: 30444930
[TBL] [Abstract][Full Text] [Related]
10. MK2/3 Are Pivotal for IL-33-Induced and Mast Cell-Dependent Leukocyte Recruitment and the Resulting Skin Inflammation.
Drube S; Kraft F; Dudeck J; Müller AL; Weber F; Göpfert C; Meininger I; Beyer M; Irmler I; Häfner N; Schütz D; Stumm R; Yakovleva T; Gaestel M; Dudeck A; Kamradt T
J Immunol; 2016 Nov; 197(9):3662-3668. PubMed ID: 27694493
[TBL] [Abstract][Full Text] [Related]
11. SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-kappa B activity.
Kalesnikoff J; Baur N; Leitges M; Hughes MR; Damen JE; Huber M; Krystal G
J Immunol; 2002 May; 168(9):4737-46. PubMed ID: 11971024
[TBL] [Abstract][Full Text] [Related]
12. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
Front Immunol; 2018; 9():2227. PubMed ID: 30319662
[TBL] [Abstract][Full Text] [Related]
13. Enhanced inducible costimulator ligand (ICOS-L) expression on dendritic cells in interleukin-10 deficiency and its impact on T-cell subsets in respiratory tract infection.
Gao X; Zhao L; Wang S; Yang J; Yang X
Mol Med; 2013 Nov; 19(1):346-56. PubMed ID: 24100657
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol inhibits IL-33-mediated mast cell activation by targeting the MK2/3-PI3K/Akt axis.
Nakajima S; Ishimaru K; Kobayashi A; Yu G; Nakamura Y; Oh-Oka K; Suzuki-Inoue K; Kono K; Nakao A
Sci Rep; 2019 Dec; 9(1):18423. PubMed ID: 31804564
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin-Rcan1 interaction contributes to stem cell factor-mediated mast cell activation.
Wu Z; Li Y; MacNeil AJ; Junkins RD; Berman JN; Lin TJ
J Immunol; 2013 Dec; 191(12):5885-94. PubMed ID: 24218457
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide mediated mast cells induce IL-10 producing regulatory T cells through the ICOSL/ICOS axis.
Nie X; Cai G; Zhang W; Wang H; Wu B; Li Q; Shen Q
Clin Immunol; 2012 Mar; 142(3):269-79. PubMed ID: 22154192
[TBL] [Abstract][Full Text] [Related]
17. Neomangiferin modulates the Th17/Treg balance and ameliorates colitis in mice.
Lim SM; Kang GD; Jeong JJ; Choi HS; Kim DH
Phytomedicine; 2016 Feb; 23(2):131-40. PubMed ID: 26926174
[TBL] [Abstract][Full Text] [Related]
18. Stem cell factor induces AP-1-dependent mast cell IL-6 production via MAPK kinase 3 activity.
MacNeil AJ; Junkins RD; Wu Z; Lin TJ
J Leukoc Biol; 2014 Jun; 95(6):903-15. PubMed ID: 24453276
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of interleukin-3 and interleukin-1 on the proliferation and interleukin-6 protein secretion of acute myeloid leukemic cells; the involvement of ERK, p38 and STAT5.
Birkenkamp KU; Esselink MT; Kruijer W; Vellenga E
Eur Cytokine Netw; 1999 Dec; 10(4):479-90. PubMed ID: 10586114
[TBL] [Abstract][Full Text] [Related]
20. Murine mast cells secrete and respond to interleukin-33.
Tung HY; Plunkett B; Huang SK; Zhou Y
J Interferon Cytokine Res; 2014 Mar; 34(3):141-7. PubMed ID: 24028396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
